Argus

•

Mar 18, 2026

Symbols

Sector(s)

Healthcare

Rating

Earnings Estimate

Current Price

$451.59

Price Target

Summary

Vertex Pharmaceuticals develops therapies to address CF and other diseases. The company was founded in 1989 in Cambridge, Massachusetts, and has 6,400 employees. It has research programs and facilities in the

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

Jasper Hellweg

Associate Analyst: Growth Pharmaceutical, Medical Technology & Financial Technology

At Argus Research, Jasper covers the Growth Pharmaceutical, Medical Technology, and Financial Technology companies. He received his undergraduate degree from Boston University, graduating cum laude with a Bachelor of Science degree in Business Administration with concentrations in Entrepreneurship and Marketing.  Prior to joining Argus, Jasper worked in a variety of industries, ranging from investment tradeshow management to musical instrument manufacturing.  He started his career at Argus in the Research department and has since widened his scope to also include becoming a regular contributor for the Market Movers and Market Digest publications, the Vickers Weekly Insider Report and Argus' bespoke research on IPOs.

Sign in to access your portfolio